PT2399 - AN OVERVIEW

lumacaftor/ivacaftor will reduce the level or impact of abemaciclib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration of abemaciclib with robust CYP3A4 inducers lessens plasma concentration of abemaciclib and its metabolites.Mobile proliferation was assessed employing a bromodeoxyurid